The US Food and Drug Administration (FDA) has allowed marketing of the Xlumena, Inc's Axios Stent and Delivery System for treating pseudocysts (fluid and tissue filled cavities) that form in the ...

On March 22, 2016, Boston Scientific announced the launch of the AXIOS Stent and Electrocautery Enhanced Delivery System. According to its website, the stent and delivery system helps physicians treat ...

MOUNTAIN VIEW, Calif., July 17, 2012 /PRNewswire/ -- Xlumena, Inc. announces that it has received CE Mark approval to market its AXIOS Stent and Delivery System for biliary tract drainage. The device ...

Please provide your email address to receive an email when new articles are posted on . Boston Scientific has launched the Axios Stent and Electrocautery Enhanced Delivery System for the endoscopic ...

Boston Scientific Corporation announced today the commercial launch of the AXIOS Stent and Electrocautery Enhanced Delivery System. It is designed to help physicians manage serious complications from ...

MOUNTAIN VIEW, Calif., May 15, 2012 /PRNewswire/ -- Xlumena, Inc. announces the publication of a scientific paper describing the first human study of the AXIOS™ Stent and Delivery System. The article, ...

The FDA has classified Boston Scientific’s removal of certain Axios Stent and Electrocautery-Enhanced Delivery Systems as a Class I recall, the agency’s most serious designation. The recall stems from ...

Axios Stent and Electrocautery Enhanced Delivery System--Courtesy of Boston Scientific Boston Scientific ($BSX) launched the Axios Stent and Electrocautery Enhanced ...

Please provide your email address to receive an email when new articles are posted on . The FDA will allow the marketing of the AXIOS Stent and Delivery System for the treatment of pseudocysts of the ...

The first stent specifically designed to treat pancreatic pseudocysts yesterday was cleared for marketing by the US Food and Drug Administration (FDA). The Axios stent and delivery system from Xlumena ...

Xlumena's Axios stent and delivery system--Courtesy of Xlumena The FDA has approved Xlumena's AXIOS stent and delivery system to treat pseudocysts of the pancreas. In its press release announcing the ...